<DOC>
	<DOCNO>NCT01703728</DOCNO>
	<brief_summary>Ovarian hyper stimulation syndrome ( OHSS ) potentially serious complication ovarian stimulation IVF ( In Vitro Fertilisation ) . The main objective study describe incidence moderate severe form OHSS woman 18 36 year age treat HP-hMG .</brief_summary>
	<brief_title>Controlled Ovarian Stimulation HP-hMG IVF / ICSI Cycles : Study Ovarian Hyper Stimulation Syndrome Cohort Women From 18 36 Years Old .</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<criteria>Women present infertility one year candidate first second IVF cycle without ICSI HPhMG prescribe COS . Absence infertility treatment last 3 month enrolment . Age : 18 36 year old . BMI 18 30 kg / m² . Presence ovaries accessible puncture absence ovarian uterine abnormality . Male female infertility . Ovarian stimulation HPhMG pituitary desensitization GnRH agonist antagonist . Normal ovarian reserve accord physician habitual evaluation . Consent participate nointerventional study signature patient ' information sheet . Presence chronic disease , cancer endocrine disease could potentially influence result stimulation represent contraindication ovarian stimulation . Known endometriosis grade III IV . Contraindication use gonadotropin current pregnancy diagnose clinician . Recurrent miscarriage , know genetic disease one partner indication preimplantation genetic diagnosis ( PGD ) . Smoking 10 cigarette / day.´ Participation interventional study time inclusion . Known poor ovarian response previous cycle stimulation ( number oocyte collect ≤ 3 , / 2 previous IVF/ICSI cycle / abnormal result ovarian reserve test ( AMH &lt; 1 ng/ml Immunotech equipment AMH &lt; 0.7 ng/ml DSL equipment ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>